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This was confirmed after contrast injec-
tion, with massive passage of micro-bub-
bles through a PFO.
Despite measures designed to reduce
especially the right heart pressure, the
shunt continued to be clinically significant,
therefore we decided to close the PFO, 
under fluoroscopy and TEE guidance using
an Amplatzer PFO occluder via a percuta-
neous approach [3]. At the end of the pro-
cedure the shunt was virtually absent on
both fluoroscopy and TEE (Fig. 1). This
was further corroborated by a marked im-
provement in arterial oxygenation during
the subsequent days. On day 16, the patient
underwent successful cardiac transplanta-
tion with a favourable clinical course.
Due to a combination of VAD-induced
left atrial and ventricular unloading a RLS
is generally observed in the presence of an
inter-atrial communication [2]. Conserva-
tive measures to reduce the degree of RLS
by lowering right-sided heart pressures,
such as reducing PEEP, reduction of the
pressure support ventilation and careful
volume management, are often insufficient.
In such cases the closure of the intra-atrial
communication is necessary, by either a
surgical or percutaneous approach [3]. Be-
cause PFOs are present in up to 30% of the
general population, peri-operative screen-
ing with a TEE should be considered prior
to implantation of a VAD [4]. Furthermore,
the TEE should be preferably performed
immediately after the VAD is activated, 
because almost 20% of PFOs can be detect-
ed only in the presence of this artificial, de-
vice-generated, right-left atrial gradient [5].
In conclusion, we suggest that when a
VAD (left, right or bi-ventricular) has to 
be implanted, patients should be screened
for an inter-atrial communication by TEE
[4, 5]. If this is present, surgical closure
should be considered during the VAD-im-
plantation [2]. However, if a clinically 
apparent shunt is documented after VAD
implantation, percutaneous closure can be
performed safely with a high success rate
[3], and should probably be considered
first-line treatment.
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Sir: Due to a shortage of donors, ventricu-
lar assist devices (VADs)—left, right or 
bi-ventricular—have been developed as a
bridge to cardiac transplantation for pa-
tients with severe congestive heart failure
(CHF) [1]. The Berlin Heart VAD is an 
external implantable device utilising an 
extracorporeal pump (or “ventricle”) with 
a compressed air system, which aspirates
blood from the atria or ventricles and
pumps it through the aorta and/or the pul-
monary trunk [1]. In the presence of an 
inter-atrial communication, i.e. patent fora-
men ovale (PFO) or atrial septum defect
(ASD), a significant right-to-left shunt
(RLS) may develop, leading to systemic
arterial desaturation [2]. We report the case
of a patient with a Berlin Heart bi-ventricu-
lar assist device (BiVAD), implanted as a
bridge to cardiac transplantation for de-
compensated CHF, complicated by a se-
vere refractory arterial hypoxemia caused
by a RLS via a PFO.
A 46-year-old male presented in cardio-
genic shock with radiological evidence of
pulmonary oedema. The coronary angiogra-
phy revealed severe three-vessel coronary
artery disease (CAD) with 10% left ventric-
ular ejection fraction at echocardiography.
Immediate revascularisation was not con-
sidered feasible and because of the rapid
clinical deterioration of the patient a Bi-
VAD, Berlin Heart Excor, was inserted as a
bridge to possible cardiac transplantation.
Due to the ameliorated haemodynam-
ics, a more aggressive vasodilatatory thera-
py was instituted, however, on the follow-
ing day unexplained recurrent arterial 
desaturation was observed, with arterial
oxygen saturations as low as 75%. A trans-
oesophageal echocardiography (TEE) was
performed to investigate a suspected RLS,
through an inter-atrial communication.
Fig. 1 Fluoroscopy image showing contrast medium (c.m. white arrow) injection in 
the right atrium (RA) without passage of c.m. through the Amplatzer PFO occluder 
(arrowhead). LA left atrium, black arrow TEE transductor
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